-

NYSE American to Suspend Trading in Enservco Corporation (ENSV)

NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to suspend trading in the common stock of Enservco Corporation (the “Company”) — ticker symbol ENSV —from the Exchange. The staff suspended trading in the Company’s common stock because the Listings Qualifications Panel (the “Panel”) of the Committee for Review of the Board of Directors of the Exchange (the “Committee”) had issued a decision in which it upheld the Exchange’s previously announced determination to delist the Company’s common stock.

The Exchange previously announced on June 10, 2024 that the Company was no longer suitable for listing pursuant to Section 1009(a) of the NYSE American Company Guide (the “Company Guide”) as the Company was unable to demonstrate that it had regained compliance with Sections 1003(a)(i), (ii) and (iii) of the Company Guide by the end of the maximum 18-month compliance plan period, which expired on June 9, 2024. The Company had the right to request a review of this delisting determination by the Panel.

The Company has a right to a review of the Panel’s decision to delist the Company’s common stock by the Committee by making a written request within 15 calendar days of the date of the Panel’s decision. The filing by the Exchange of an application with the Securities and Exchange Commission to delist the Company’s common stock is pending completion of all applicable procedures, including any appeal by the Company of the Panel’s decision.

Contacts

Company Contacts:
Mark Patterson
Chief Financial Officer
Enservco Corporation
mpatterson@enservco.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

NYSE Regulation


Release Versions

Contacts

Company Contacts:
Mark Patterson
Chief Financial Officer
Enservco Corporation
mpatterson@enservco.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

More News From NYSE Regulation

NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common stock of Vicarious Surgical Inc. (the “Company”) — ticker symbol RBOT — from the NYSE. Trading in the Company’s Class A common stock will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s Class A common stock pursuant to Section 802.01B of the NYSE’s Listed Compan...

NYSE to Commence Delisting Proceedings Against Trinseo PLC (TSE)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the ordinary shares of Trinseo PLC (the “Company”) — ticker symbol TSE — from the NYSE. Trading in the Company’s ordinary shares will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s ordinary shares pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company...

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities enumerated below (“Securities”) of Allurion Technologies, Inc. (the “Company”) from the NYSE. Trading in these Securities will continue on the NYSE until such time as described below. Symbol Description ALUR Common stock, par value $0.0001 per share ALUR WS Warrants to purchase 0.056818 shares of com...
Back to Newsroom